[{"id":"a78c23c8-685c-4a20-b296-23606edfb366","acronym":"ENZYMELA","url":"https://clinicaltrials.gov/study/NCT04253080","created_at":"2023-02-15T23:01:10.084Z","updated_at":"2024-07-02T16:35:24.158Z","phase":"","brief_title":"Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors","source_id_and_acronym":"NCT04253080 - ENZYMELA","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","biomarkers":" IL4I1","pipe":"","alterations":" ","tags":["IL4I1"],"overall_status":"Recruiting","enrollment":" Enrollment 170","initiation":"Initiation: 04/12/2022","start_date":" 04/12/2022","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 02/01/2025","study_completion_date":" 02/01/2025","last_update_posted":"2024-01-09"}]